Researchers evaluated the effectiveness of adeno-associated virus (AAV)-mediated Plakophilin 2 (PKP2) delivery in treating arrhythmogenic cardiomyopathy (ACM).
Gene therapy shows promise for arrhythmogenic cardiomyopathy
- Post author:
- Post published:December 12, 2023
- Post category:uncategorized